Circulating and Tissue-Resident CD4<sup>+</sup> T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation.
Hegazy AN, West NR, Stubbington MJT, Wendt E, Suijker KIM, Datsi A, This S, Danne C, Campion S, Duncan SH, Owens BMJ, Uhlig HH, McMichael A, Oxford IBD Cohort Investigators, Bergthaler A, Teichmann SA, Keshav S, Powrie F. · 2017
Read Circulating and Tissue-Resident CD4<sup>+</sup> T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation. by Hegazy AN, West NR, Stubbington MJT, Wendt E, Suijker KIM, Datsi A, This S, Danne C, Campion S, Duncan SH, Owens BMJ, Uhlig HH, McMichael A, Oxford IBD Cohort Investigators, Bergthaler A, Teichmann SA, Keshav S, Powrie F. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5687320.txt.
Introduction
Hegazy and co-authors report an immunology study in Gastroenterology. It measures human T cells that react to gut bacteria. Such microbe-immune contact keeps the gut in balance. How it works in humans was poorly known. The team sampled blood and gut tissue from healthy people. Samples also came from 119 bowel disease patients. Nine gut bacterial species were used as test targets. Two assays counted and grew the reactive cells.
Reactive CD4 cells proved common in healthy controls. They sat in both blood and intestinal tissue. Most carried a memory phenotype with varied receptors. They made barrier-protective signals and stimulated gut lining cells. In bowel disease, blood levels of these cells dropped. Their gut responses also shifted toward more IL-17A.
Catalog record
| CREATOR | Hegazy AN, West NR, Stubbington MJT, Wendt E, Suijker KIM, Datsi A, This S, Danne C, Campion S, Duncan SH, Owens BMJ, Uhlig HH, McMichael A, Oxford IBD Cohort Investigators, Bergthaler A, Teichmann SA, Keshav S, Powrie F. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 89 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Circulating and Tissue-Resident CD4+ T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation By Ahmed N Hegazy, Nathaniel R West, Michael JT Stubbington, Emily Wendt, Kim IM Suijker, Angeliki Datsi, Sebastien This, Camille Danne, Suzanne Campion, Sylvia H Duncan, Benjamin MJ Owens, Holm H Uhlig Published in: Gastroenterology DOI: 10.1053/j.gastro.2017.07.047 ABSTRACT Abstract Background & Aims Interactions between commensal microbes and the immune system are tightly regulated and maintain intestinal homeostasis, but little is known about these interactions in humans. We investigated responses of human CD4+ T cells to the intestinal microbiota. We measured the abundance of T cells in circulation and intestinal tissues that respond to intestinal microbes and determined their clonal diversity. We also assessed their functional phenotypes and effects on intestinal resident cell populations, and studied alterations in microbe-reactive T cells in patients with chronic intestinal inflammation. Methods We collected samples of peripheral blood mononuclear cells and intestinal tissues from healthy individuals (controls, n = 13−30) and patients with inflammatory bowel diseases (n = 119; 59 with ulcerative colitis and 60 with Crohn’s disease). We used 2 independent assays (CD154 detection and carboxy-fluorescein succinimidyl ester dilution assays) and 9 intestinal bacterial species (Escherichia coli, Lactobacillus acidophilus, Bifidobacterium animalis subsp lactis, Faecalibacterium prausnitzii, Bacteroides vulgatus, Roseburia intestinalis, Ruminococcus obeum, Salmonella typhimurium, and Clostridium difficile) to quantify, expand, and characterize microbe-reactive CD4+ T cells. We sequenced T-cell receptor Vβ genes in expanded microbe-reactive T-cell lines to determine their clonal diversity. We examined the effects of microbe-reactive CD4+ T cells on intestinal stromal and epithelial cell lines. Cytokines, chemokines, and gene expression patterns were measured by flow cytometry and quantitative polymerase chain reaction. Results Circulating and gut-resident CD4+ T cells from controls responded to bacteria at frequencies of 40−4000 per million for each bacterial species tested. Microbiota-reactive CD4+ T cells were mainly of a memory phenotype, present in peripheral blood mononuclear cells and intestinal tissue, and had a diverse T-cell receptor Vβ repertoire. These cells were functionally heterogeneous, produced barrier-protective cytokines, and stimulated intestinal stromal and epithelial cells via interleukin 17A, interferon gamma, and tumor necrosis factor. In patients with inflammatory bowel diseases, microbiota-reactive CD4+ T cells were reduced in the blood compared with intestine; T-cell responses that we detected had an increased frequency of interleukin 17A production compared with responses of T cells from blood or intestinal tissues of controls. Conclusions In an analysis of peripheral blood mononuclear cells and intestinal tissues from patients with inflammatory bowel diseases vs controls, we found that reactivity to intestinal bacteria is a normal property of the human CD4+ T-cell repertoire, and does not necessarily indicate disrupted interactions between immune cells and the commensal microbiota. T-cell responses to commensals might support intestinal homeostasis, by producing barrier-protective cytokines and providing a large pool of T cells that react to pathogens. Keywords: Immune Regulation, Microbiota, Cytokines, Tissue-resident Memory T cells Abbreviations used in this paper: CFSE, carboxy-fluorescein succinimidyl ester; IBD, inflammatory bowel disease; ICOS, inducible T-cell costimulator; IFN, interferon; IL, interleukin; LPMC, Lamina propria mononuclear cell; PBMC, peripheral blood mononuclear cell; SEB, Staphylococcus enterotoxin B; TCR, T-cell receptor; Th, T helper; TNF, tumor necrosis factor See Covering the Cover synopsis on page 1175. Editor's NotesBackground and ContextCD4+ T cell responses to intestinal bacteria are known to occur, however these responses remain poorly characterized in humans.New FindingsMicrobiota-reactive CD4+ T cells are prevalent and normal constituents of the human immune system that are functionally altered during IBD pathogenesis.LimitationsThe functional relevance of the detected T-cell responses in humans remains to be elucidated.ImpactT-cell responses to commensals might support intestinal homeostasis by producing barrier-protective cytokines and providing a large pool of T cells with potential cross-reactivity to pathogens. Vast numbers of microbes populate the gastrointestinal tract and contribute to digestion, epithelial barrier integrity, and development of appropriately educated mucosal immunity.1 Intestinal immune responses are tightly regulated to allow protective immunity against pathogens, while limiting responses to dietary antigens and innocuous microbes. The “mucosal firewall” prevents systemic dissemination of microbes by confining microbial antigens to the gut-associated lymphoid tissue.2 In the gut-associated lymphoid tissue, dendritic cells drive regulatory T-cell differentiation in response to dietary antigens and commensal bacteria.3 Nevertheless, vast numbers of potentially commensal-reactive effector and memory T cells populate intestinal mucosae.4 Recent evidence suggests that in mice, tolerance to commensal-derived antigens may be lost during pathogen-induced epithelial damage and subsequent transient exposure to commensals.1, 5 In humans, circulating memory T cells recognize peptides derived from gut bacteria and can cross-react to pathogens, which can confer immunologic advantage during subsequent new infections.6, 7 Although this process can be beneficial during homeostasis, deranged responses to commensals may promote inflammatory conditions, such as inflammatory bowel diseases (IBDs). IBDs (including Crohn’s disease and ulcerative colitis) result from a prolonged disturbance of gut homeostasis, the precise etiology of which is uncertain. One hypothesis is that, in genetically susceptible individuals, IBD may be triggered by intestinal dysbiosis that promotes aberrant immune stimulation.8 Indeed, in mouse models of colitis, intestinal microbiota promote inflammation in part by stimulating microbiota-reactive CD4+ T cells.5, 9 Whether this drives IBD in humans, however, remains unknown. Although CD4+ T-cell responses to intestinal bacteria are known to occur in humans,10, 11, 12 several aspects of this topic are largely uncharacterized, including the frequency of human T cells in the gut and periphery that are reactive to phylogenetically distinct intestinal microbes; the T-cell receptor (TCR) diversity and clonotype sharing of these T cells; the functional phenotype of gut microbe-reactive T cells and their impact on tissue-resident cell populations; and how microbe-reactive T cells change during chronic intestinal inflammation. To address this knowledge gap, we extensively characterized CD4+ T-cell responses to intestinal microbiota in healthy individuals and IBD patients. Using 2 independent assays, we observed that for almost all enteric bacteria examined, bacteria-reactive CD4+ T cells were present at a frequency of 40−500 per million CD4+ T cells in adult peripheral blood. Bacteria-reactive T cells were also prevalent in the gut mucosa, with prominent enrichment for proteobacteria reactivity. Microbiota-responsive T cells showed a diverse TCR Vβ repertoire and potently stimulated inflammatory responses by intestinal epithelial and stromal cells. Intriguingly, T cells from IBD patients displayed a normal spectrum of microbial responses, but expressed high amounts of interleukin (IL) 17A, consistent with increased amounts of T-helper (Th) 17-polarizing cytokines in inflamed intestinal tissue. Collectively, these data demonstrate that microbiota-reactive CD4+ T cells are prevalent and normal constituents of the human immune system that are functionally altered during IBD pathogenesis. MATERIALS AND METHODS Human Samples and Cell Isolation Leukoreduction chambers from healthy individuals were obtained from the National Blood Service (Bristol, UK). Peripheral EDTA blood samples were obtained from IBD patients attending the John Radcliffe Hospital Gastroenterology unit or from healthy in-house volunteers. IBD patients (n = 119; ulcerative colitis, n = 59; Crohn’s disease, n = 60) diagnosed by endoscopic, histologic, and radiologic criteria were recruited for the study. Healthy volunteers (n = 30) without any known underlying acute or chronic pathologic condition served as control donors. All donors provided informed written consent. The National Health Service Research Ethics System provided ethical approval (reference numbers 09/H0606/5 for IBD patients and 11/YH/0020 for controls; OCHRe ref 15/A237 for cord